Roche's Genentech and Sangamo enter neurodegenerative disease partnership worth over $1.9bn

Retrieved on: 2024-08-08 12:16:44

Tags for this article:

Click the tags to see associated articles and topics

Roche's Genentech and Sangamo enter neurodegenerative disease partnership worth over $1.9bn. View article details on hiswai:

Excerpt

According to WHO, neurological conditions are now the leading cause of ill health and disability worldwide. - PMLiVE. Roche's Genentech and ...

Article found on: pmlive.com